Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2012 Dec;55(12):1707-18. doi: 10.1093/cid/cis797. Epub 2012 Sep 12.

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.

Collaborators (375)

Grosskurth H, Munderi P, Kabuye G, Nsibambi D, Kasirye R, Zalwango E, Nakazibwe M, Kikaire B, Nassuna G, Massa R, Fadhiru K, Namyalo M, Zalwango A, Generous L, Khauka P, Rutikarayo N, Nakahima W, Mugisha A, Todd J, Levin J, Muyingo S, Ruberantwari A, Kaleebu P, Yirrell D, Ndembi N, Lyagoba F, Hughes P, Aber M, Lara A, Foster S, Amurwon J, Wakholi B, Whitworth J, Wangati K, Amuron B, Kajungu D, Nakiyingi J, Omony W, Fadhiru K, Nsibambi D, Khauka P, Mugyenyi P, Kityo C, Ssali F, Tumukunde D, Otim T, Kabanda J, Musana H, Akao J, Kyomugisha H, Byamukama A, Sabiiti J, Komugyena J, Wavamunno P, Mukiibi S, Drasiku A, Byaruhanga R, Labeja O, Katundu P, Tugume S, Awio P, Namazzi A, Bakeinyaga G, Katabira H, Abaine D, Tukamushaba J, Anywar W, Ojiambo W, Angweng E, Murungi S, Haguma W, Atwiine S, Kigozi J, Namale L, Mukose A, Mulindwa G, Atwiine D, Muhwezi A, Nimwesiga E, Barungi G, Takubwa J, Murungi S, Mwebesa D, Kagina G, Mulindwa M, Ahimbisibwe F, Mwesigwa P, Akuma S, Zawedde C, Nyiraguhirwa D, Tumusiime C, Bagaya L, Namara W, Kigozi J, Karungi J, Kankunda R, Enzama R, Latif A, Hakim J, Robertson V, Reid A, Chidziva E, Bulaya-Tembo R, Musoro G, Taziwa F, Chimbetete C, Chakonza L, Mawora A, Muvirimi C, Tinago G, Svovanapasis P, Simango M, Chirema O, Machingura J, Mutsai S, Phiri M, Bafana T, Chirara M, Muchabaiwa L, Muzambi M, Mutowo J, Chivhunga T, Chigwedere E, Pascoe M, Warambwa C, Zengeza E, Mapinge F, Makota S, Jamu A, Ngorima N, Chirairo H, Chitsungo S, Chimanzi J, Maweni C, Warara R, Matongo M, Mudzingwa S, Jangano M, Moyo K, Vere L, Mdege N, Machingura I, Katabira E, Ronald A, Kambungu A, Lutwama F, Mambule I, Nanfuka A, Walusimbi J, Nabankema E, Nalumenya R, Namuli T, Kulume R, Namata I, Nyachwo L, Florence A, Kusiima A, Lubwama E, Nairuba R, Oketta F, Buluma E, Waita R, Ojiambo H, Sadik F, Wanyama J, Nabongo P, Oyugi J, Sematala F, Muganzi A, Twijukye C, Byakwaga H, Ochai R, Muhweezi D, Coutinho A, Etukoit B, Gilks C, Boocock K, Puddephatt C, Grundy C, Bohannon J, Winogron D, Gibb D, Burke A, Babiker A, Walker A, Wilkes H, Rauchenberger M, Sheehan S, Spencer-Drake C, Taylor K, Spyer M, Ferrier A, Naidoo B, Dunn D, Goodall R, Darbyshire J, Peto L, Nanfuka R, Mufuka-Kapuya C, Weller I, Babiker A, Bahendeka S, Bassett M, Wapakhabulo A, Darbyshire J, Gazzard B, Gilks C, Grosskurth H, Hakim J, Latif A, Mapuchere C, Mugurungi O, Mugyenyi P, Burke C, Jones S, Newland C, Pearce G, Rahim S, Rooney J, Smith M, Snowden W, Steens J-, Breckenridge A, McLaren A, Hill C, Matenga J, Pozniak A, Serwadda D, Peto T, Palfreeman A, Borok M, Katabira E, Mugyenyi P, Musiime V, Afayo V, Bagurukira E, Bwomezi J, Byaruhanga J, Erimu P, Karungi C, Kizito H, Mutumba M, Namala W, Namusanje J, Nandugwa R, Najjuko T, Natukunda E, Ndigendawani M, Nsiyona S, Odongo F, Robinah K, Ssenyonga M, Sseremba D, Tezikyabbiri J, Tumusiime C, Munderi P, Nahirya-Ntege P, Aber M, Kaggwa F, Kaleebu P, Katuramu R, Kyalimpa J, Lutaakome J, Matama L, Musinguzi M, Nabulime G, Ruberantwari A, Sebukyu R, Ssekamatte I, Tushabe G, Wangi D, Kekitiinwa A, Musoke P, Bakeera-Kitaka S, Namuddu R, Kasirye P, Balungi J, Babirye A, Asello J, Nakalanzi S, Ssemambo N, Nakafeero J, Kairu J, George E, Musoba G, Ssanyu J, Ssenyonjo S, Nathoo K, Bwakura-Dangarembizi M, Mapinge F, Mhute T, Vhembo T, Mandidewa R, Nyoni D, Katanda C, Tinago G, Bhiri J, Muchabaiwa D, Mudzingwa S, Chipiti M, Phiri M, Steamer J, Marozva C, Maturure S, Matanhike L, Tsikirayi S, Munetsi L, Gibb D, Thomason M, Cook A, Crawley J, Ferrier A, Naidoo B, Spyer M, Walker A, Kendall L, Nanfuka R, Machuringa I, Weller I, Luyirika E, Lyall H, Malianga E, Mwansambo C, Nyathi M, Wapakhabulo A, Gibb D, Kekitiinwa A, Mugyenyi P, Munderi P, Nathoo K, Kinn S, MacNeil M, Roberts M, Snowden W, Breckenridge A, Hill C, Matenga J, Pozniak A, Tumwine J, Barigye H, Mujuru H, Ndeezi G, Watera C, Miiro G, Zawedde S, Nakiyingi J, Rutebarika D, Grosskurth H, Zar H, Eley B, Roux P, Cotton M, Meyers T, Moultrie H, Mulenga V, Chintu C, Kankasa C, Msellati P, Fassinou P, Elenga N, Graham S, Ellis J, Weigel R, Giaquinto C, Nanyonga M, Morelli E, Atai B, Pinto J, Araújo C, Carvalho A, Carvalho I, Diniz A, Ferreira F, Lobato V, Sanchez T.

Abstract

BACKGROUND:

Adult mortality in the first 3 months on antiretroviral therapy (ART) is higher in low-income than in high-income countries, with more similar mortality after 6 months. However, the specific patterns of changing risk and causes of death have rarely been investigated in adults, nor compared with children in low-income countries.

METHODS:

We used flexible parametric hazard models to investigate how mortality risks varied over the first year on ART in human immunodeficiency virus-infected adults (aged 18-73 years) and children (aged 4 months to 15 years) in 2 trials in Zimbabwe and Uganda.

RESULTS:

One hundred seventy-nine of 3316 (5.4%) adults and 39 of 1199 (3.3%) children died; half of adult/pediatric deaths occurred in the first 3 months. Mortality variation over year 1 was similar; at all CD4 counts/CD4%, mortality risk was greatest between days 30 and 50, declined rapidly to day 180, then declined more slowly. One-year mortality after initiating ART with 0-49, 50-99 or ≥ 100 CD4 cells/μL was 9.4%, 4.5%, and 2.9%, respectively, in adults, and 10.1%, 4.4%, and 1.3%, respectively, in children aged 4-15 years. Mortality in children aged 4 months to 3 years initiating ART in equivalent CD4% strata was also similar (0%-4%: 9.1%; 5%-9%: 4.5%; ≥ 10%: 2.8%). Only 10 of 179 (6%) adult deaths and 1 of 39 (3%) child deaths were probably medication-related. The most common cause of death was septicemia/meningitis in adults (20%, median 76 days) and children (36%, median 79 days); pneumonia also commonly caused child deaths (28%, median 41 days).

CONCLUSIONS:

Children ≥ 4 years and adults with low CD4 values have remarkably similar, and high, mortality risks in the first 3 months after ART initiation in low-income countries, similar to cohorts of untreated individuals. Bacterial infections are a major cause of death in both adults and children; targeted interventions could have important benefits.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk